Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
30.32
-0.21 (-0.69%)
Oct 10, 2025, 2:59 PM EDT - Market open

Vera Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
62.924123.7921.9111.924.04
Research & Development
173.13126.1778.2368.9922.4845.21
Other Operating Expenses
-----3
Total Operating Expenses
236.05167.17102.0190.934.452.24
Operating Income
-236.05-167.17-102.01-90.9-34.4-52.24
Interest Income
24.6520.717.981.750.020.01
Interest Expense
-7.47-7.63-3.79-0.99-0.02-0.17
Other Non-Operating Income (Expense)
0.591.941.831.091.8-1.01
Total Non-Operating Income (Expense)
17.7715.026.021.851.79-1.17
Pretax Income
-218.28-152.15-95.99-89.06-32.61-53.41
Provision for Income Taxes
-00000
Net Income
-218.28-152.15-95.99-89.06-32.61-53.41
Net Income to Common
-218.28-152.15-95.99-89.06-32.61-53.41
Shares Outstanding (Basic)
61554327130
Shares Outstanding (Diluted)
61554327130
Shares Change (YoY)
24.99%29.55%60.73%97.76%4099.14%-
EPS (Basic)
-3.58-2.75-2.25-3.35-2.43-166.93
EPS (Diluted)
-3.58-2.75-2.25-3.35-2.43-166.93
Free Cash Flow
-186.55-135.65-92.24-67.66-23.71-34.91
Free Cash Flow Per Share
-3.07-2.45-2.16-2.55-1.76-109.10
EBITDA
-233.82-165-99.77-89.48-34.23-51.99
EBIT
-236.05-167.17-102.01-90.9-34.4-52.24
Effective Tax Rate
0.00%-0.00%-0.00%-0.00%-0.00%-0.00%
Updated Aug 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q